Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 30,911 |
|
|||||
| News | - | ||||||
| Day High | 1.5461 | Low High |
|||||
| Day Low | 1.37 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.1526 | 11.22% | 1.5126 | 12:18:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.38 | 1.37 | 1.5461 | 1.36 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 179 | 30,911 | US$ 1.47 | US$ 45,315 | - | 1.22 - 20.66 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 12:17:10 | 53 | US$ 1.53 | USD |
Hepion Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.99M | 4.34M | - | 0 | -48.93M | -11.28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Hepion Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.2998 | 1.5461 | 1.27 | 1.35 | 19,343 | 0.2128 | 16.37% |
| 1 Month | 2.55 | 2.8999 | 1.22 | 1.83 | 50,732 | -1.04 | -40.68% |
| 3 Months | 1.56 | 3.4899 | 1.22 | 2.23 | 75,566 | -0.0474 | -3.04% |
| 6 Months | 4.40 | 4.47 | 1.22 | 2.60 | 73,798 | -2.89 | -65.62% |
| 1 Year | 13.40 | 20.66 | 1.22 | 12.67 | 147,277 | -11.89 | -88.71% |
| 3 Years | 35.60 | 46.368 | 1.22 | 26.67 | 522,556 | -34.09 | -95.75% |
| 5 Years | 62.20 | 167.00 | 1.22 | 45.74 | 1,019,929 | -60.69 | -97.57% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. |
